This case highlights the importance of recognizing ICPI-AKI, implementing effective therapeutic interventions, and understanding the clinical context to prevent irreversible renal damage.
George DeMaagd, PharmD, BCPS
Advertisement
Articles by George DeMaagd, PharmD, BCPS
Migraine is a chronic neurological disease characterized by throbbing or pulsating unilateral or bilateral headache that can last from hours to days.
Advertisement
Latest Updated Articles
- What You Need to Know About Alzheimer's Disease
Published: January 1st 2006 | Updated:
- Migraine Headache: The Pharmacist and the Role of OTC Medications
Published: March 1st 2007 | Updated:
- Obesity: A Growing Pharmacologic Challenge
Published: November 1st 2006 | Updated:
- What You Need to Know About Alzheimer's Disease
Published: January 1st 2006 | Updated:
- Management of Heart Failure: A Brief Update
Published: December 1st 2005 | Updated:
- ACEIs: A Brief Review of Their Pharmacotherapeutic Uses
Published: September 1st 2004 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
FDA Initiates Approval of Leucovorin for Patients With Cerebral Folate Deficiency
2
Rapid CAR T Expansion Linked to Delayed Neurotoxicity in Patients Treated With Cilta-Cel
3
Hercessi, Biosimilar to Herceptin, Shows Favorable Efficacy, Safety in Treating HER2+ MBC in Real-World Setting
4
IMS: Shaping the Future of Multiple Myeloma with Anti-CD38 Quadruplets
5
